AMRUTANJAN HEALTH CARE
Quarterly Results Analysis [Sep2024]
AMRUTANJAN HEALTH CARE Quarterly Results
Standalone | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹110 Cr | ₹84 Cr | ₹127 Cr | ₹117 Cr | ₹99 Cr | ₹78 Cr | ₹100 Cr | ₹98 Cr |
Expenses | ₹96 Cr | ₹80 Cr | ₹111 Cr | ₹95 Cr | ₹92 Cr | ₹71 Cr | ₹87 Cr | ₹85 Cr |
Operating Income | ₹14 Cr | ₹4 Cr | ₹16 Cr | ₹22 Cr | ₹7 Cr | ₹7 Cr | ₹13 Cr | ₹12 Cr |
Other Income | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹16 Cr | ₹6 Cr | ₹20 Cr | ₹24 Cr | ₹9 Cr | ₹9 Cr | ₹16 Cr | ₹15 Cr |
Profit After Tax | ₹12 Cr | ₹5 Cr | ₹14 Cr | ₹17 Cr | ₹7 Cr | ₹7 Cr | ₹13 Cr | ₹11 Cr |
EPS | ₹4.08 | ₹1.60 | ₹4.72 | ₹6.04 | ₹2.37 | ₹2.40 | ₹4.34 | ₹3.66 |
Industry Peers & Returns | 1W | 1M | 1Y |
AMRUTANJAN HEALTH CARE | -4.3% | -8.9% | 19.1% |
SUN PHARMACEUTICAL INDUSTRIES | -5.8% | -3.2% | 35.1% |
CIPLA | -3.9% | -0.5% | 13.9% |
DR REDDYS LABORATORIES | -1.2% | 7.1% | 17.8% |
ZYDUS LIFESCIENCES | -2.7% | -0.1% | 40.9% |
DIVIS LABORATORIES | -2.8% | -3.6% | 44.7% |
MANKIND PHARMA | -11.2% | -2.3% | 33.6% |
TORRENT PHARMACEUTICALS | -4.8% | -2.7% | 40.1% |
LUPIN | -8.6% | 1.8% | 56.9% |
AMRUTANJAN HEALTH CARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 31.26 % |
Y-o-Y | 10.68 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹110 Cr | 31.26 | |
Jun2024 | ₹84 Cr | -34.10 | |
Mar2024 | ₹127 Cr | 8.61 | |
Dec2023 | ₹117 Cr | 17.80 | |
Sep2023 | ₹99 Cr | 27.55 | |
Jun2023 | ₹78 Cr | -22.38 | |
Mar2023 | ₹100 Cr | 2.74 | |
Dec2022 | ₹98 Cr | - |
AMRUTANJAN HEALTH CARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 283.37 % |
Y-o-Y | 98.77 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹14 Cr | 283.37 | |
Jun2024 | ₹4 Cr | -78.15 | |
Mar2024 | ₹16 Cr | -24.74 | |
Dec2023 | ₹22 Cr | 215.27 | |
Sep2023 | ₹7 Cr | -4.40 | |
Jun2023 | ₹7 Cr | -44.85 | |
Mar2023 | ₹13 Cr | 6.76 | |
Dec2022 | ₹12 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 191.98 % |
Y-o-Y | 79.68 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 12.38% | 191.98 | |
Jun2024 | 4.24% | -66.82 | |
Mar2024 | 12.78% | -30.69 | |
Dec2023 | 18.44% | 167.63 | |
Sep2023 | 6.89% | -25.03 | |
Jun2023 | 9.19% | -28.98 | |
Mar2023 | 12.94% | 3.94 | |
Dec2022 | 12.45% | - |
AMRUTANJAN HEALTH CARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 155.60 % |
Y-o-Y | 72.20 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹12 Cr | 155.60 | |
Jun2024 | ₹5 Cr | -66.21 | |
Mar2024 | ₹14 Cr | -21.73 | |
Dec2023 | ₹17 Cr | 154.76 | |
Sep2023 | ₹7 Cr | -2.32 | |
Jun2023 | ₹7 Cr | -44.76 | |
Mar2023 | ₹13 Cr | 18.52 | |
Dec2022 | ₹11 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 94.74 % |
Y-o-Y | 55.51 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 10.73 % | 94.74 | |
Jun2024 | 5.51 % | -48.74 | |
Mar2024 | 10.75 % | -27.95 | |
Dec2023 | 14.92 % | 116.23 | |
Sep2023 | 6.9 % | -23.42 | |
Jun2023 | 9.01 % | -28.77 | |
Mar2023 | 12.65 % | 15.31 | |
Dec2022 | 10.97 % | - |
AMRUTANJAN HEALTH CARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 155.00 % |
Y-o-Y | 72.15 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹4.08 | 155.00 | |
Jun2024 | ₹1.6 | -66.10 | |
Mar2024 | ₹4.72 | -21.85 | |
Dec2023 | ₹6.04 | 154.85 | |
Sep2023 | ₹2.37 | -1.25 | |
Jun2023 | ₹2.4 | -44.70 | |
Mar2023 | ₹4.34 | 18.58 | |
Dec2022 | ₹3.66 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD